Rubrik RBRK · NYSE
$114.73 +2.06% (+$2.32)
Summary
47 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 44% this fiscal year.
- Revenue grew by 21% a year over the last 3 years.
- Out of every 100 USD of revenue, 21 USD is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 21% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 44%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $254.4M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 3.5 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 22
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $105.08 is 8.4% below today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Subscription and Circulation 96%
- Product and Service, Other 4.0%
By region
- Americas 72%
- EMEA 24%
- Asia Pacific 3.9%
Subscription and Circulation brings in 96% of revenue.
Segments in detail